Supplementary Figure 5 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Cao,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yan Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.22497144

2023-01-01

Abstract:Supplementary Figure 5 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

What problem does this paper attempt to address?

Supplementary Figure 4 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Cao,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yan Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.22497147

2023-01-01

Abstract:Supplementary Figure 4 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Supplementary Figure 6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Chen,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yi Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.22497141.v1

2023-01-01

Abstract:Supplementary Figure 6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Supplementary Figure 2 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Chen,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yi Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.22497153.v1

2023-01-01

Abstract:Supplementary Figure 2 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Supplementary Figure Legends 1-6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Cao,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yan Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.22497138

2023-01-01

Abstract:Supplementary Figure Legends 1-6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Data from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Jing Li,Bo Cao,Xichun Liu,Xueqi Fu,Zhenggang Xiong,Li Chen,Oliver Sartor,Yan Dong,Haitao Zhang

DOI: https://doi.org/10.1158/1535-7163.c.6535509

2023-01-01

Abstract:AbstractThe androgen receptor (AR) is critical in the normal development and function of the prostate, as well as in prostate carcinogenesis. Androgen deprivation therapy is the mainstay in the treatment of advanced prostate cancer; however, after an initial response, the disease inevitably progresses to castration-resistant prostate cancer (CRPC). Recent evidence suggests that continued AR activation, sometimes in a ligand-independent manner, is commonly associated with the development of CRPC. Thus, novel agents targeting the AR are urgently needed as a strategic step in developing new therapies for this disease state. In this study, we investigated the effect of berberine on AR signaling in prostate cancer. We report that berberine decreased the transcriptional activity of AR. Berberine did not affect AR mRNA expression, but induced AR protein degradation. Several ligand-binding, domain-truncated AR splice variants have been identified, and these variants are believed to promote the development of CRPC in patients. Interestingly, we found that these variants were more susceptible to berberine-induced degradation than the full-length AR. Furthermore, although the growth of LNCaP xenografts in nude mice was inhibited by berberine, and AR expression was reduced in the tumors, the morphology and AR expression in normal prostates were not affected. This study is the first to show that berberine suppresses AR signaling and suggests that berberine, or its derivatives, presents a promising agent for the prevention and/or treatment of prostate cancer. Mol Cancer Ther; 10(8); 1346–56. ©2011 AACR.
Supplementary Figures S1 - S7 from Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway

Hyeon Jeong Lee,Jie Li,Renee E. Vickman,Junjie Li,Rui Liu,Abigail C. Durkes,Bennett D. Elzey,Shuhua Yue,Xiaoqi Liu,Timothy L. Ratliff,Ji-Xin Cheng

DOI: https://doi.org/10.1158/1541-7786.22515313.v1

2023-01-01

Abstract:Supplementary figure S1 shows CE depletion by avasimibe treatment in prostate cancer cells. Supplementary figure S2 shows prostate cancer migration suppressed by ACAT inhibition. Supplementary figure S3 shows suppression of prostate cancer metastasis by targeting cholesterol esterification. Supplementary figure S4 shows expression profiling of prostate cancer-related genes after ACAT inhibition. Supplementary figure S5 shows inactivation of Wnt/beta-catenin pathway by ACAT-1 knockdown. Supplementary figure S6 shows inactivation of Wnt/beta-catenin pathway by cholesteryl ester depletion in multiple prostate cancer cell lines. Supplementary figure S7 shows inactivation of Wnt by ACAT-1 knockdown.
Berberine Inhibits Androgen Synthesis by Interaction with Aldo-Keto Reductase 1C3 in 22rv1 Prostate Cancer Cells

Yuantong Tian,Lijing Zhao,Ye Wang,Haitao Zhang,Duo Xu,Xuejian Zhao,Yi Li,Jing Li

DOI: https://doi.org/10.4103/1008-682x.169997

2015-01-01

Asian Journal of Andrology

Abstract:Aldo-keto reductase family 1 member C3 has recently been regarded as a potential therapeutic target in castrate-resistant prostate cancer. Herein, we investigated whether berberine delayed the progression of castrate-resistant prostate cancer by reducing androgen synthesis through the inhibition of Aldo-keto reductase family 1 member C3. Cell viability and cellular testosterone content were measured in prostate cancer cells. Aldo-keto reductase family 1 member C3 mRNA and protein level were detected by RT-PCR and Western bolt analyses, respectively. Computer analysis with AutoDock Tools explored the molecular interaction of berberine with Aldo-keto reductase family 1 member C3. We found that berberine inhibited 22Rv1 cells proliferation and decreased cellular testosterone formation in a dose-dependent manner. Berberine inhibited Aldo-keto reductase family 1 member C3 enzyme activity, rather than influenced mRNA and protein expressions. Molecular docking study demonstrated that berberine could enter the active center of Aldo-keto reductase family 1 member C3 and form p-p interaction with the amino-acid residue Phe306 and Phe311. In conclusion, the structural interaction of berberine with Aldo-keto reductase family 1 member C3 is attributed to the suppression of Aldo-keto reductase family 1 member C3 enzyme activity and the inhibition of 22Rv1 prostate cancer cell growth by decreasing the intracellular androgen synthesis. Our result provides the experimental basis for the design, research, and development of AKR1C3 inhibitors using berberine as the lead compound.
Supplementary Figure 4 from Spongian Diterpenoids Inhibit Androgen Receptor Activity

Yu Chi Yang,Labros G. Meimetis,Amy H. Tien,Nasrin R. Mawji,Gavin Carr,Jun Wang,Raymond J. Andersen,Marianne D. Sadar

DOI: https://doi.org/10.1158/1535-7163.22497567.v1

2023-01-01

Abstract:PDF File - 72K, Levels of AR protein in cell lines.
Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Nicola J. Clegg,John Wongvipat,James D. Joseph,Chris Tran,Samedy Ouk,Anna Dilhas,Yu Chen,Kate Grillot,Eric D. Bischoff,Ling Cai,Anna Aparicio,Steven Dorow,Vivek K. Arora,Gang Song,Qian Jiang,Hong Zhao,Guangbin Yang,Changyong Cao,John Sensintaffar,Teresa Wasielewska,Mark R. Herbert,Céline Bonnefous,Beatrice Darimont,Howard I. Scher,Peter Smith‐Jones,Mark Klang,Nicholas D. Smith,Elisa de Stanchina,Nanping Wu,Ouathek Ouerfelli,Peter J. Rix,Richard A. Heyman,Michael E. Jung,Charles L. Sawyers,Jeffrey H. Hager

DOI: https://doi.org/10.1158/0008-5472.22393727.v1

2023-01-01

Abstract:PDF file- 366K
Supplementary Figure from Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation

Jake L. Owens,Elena Beketova,Sheng Liu,Qi Shen,Jogendra Singh Pawar,Andrew M. Asberry,Jie Yang,Xuehong Deng,Bennett D. Elzey,Timothy L. Ratliff,Liang Cheng,Richard Choo,Deborah E. Citrin,Thomas J. Polascik,Bangchen Wang,Jiaoti Huang,Chenglong Li,Jun Wan,Chang-Deng Hu

DOI: https://doi.org/10.1158/1535-7163.22522806.v1

2023-01-01

Abstract:Supplementary Figure from Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation
Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth Through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Haiyan Qin,Dimitrios Iliopoulos,Tatsuya Nakamura,Stefan Costinean,Stefano Volinia,Teresa Druck,Jun Sun,Hiroshi Okumura,Kay Huebner

DOI: https://doi.org/10.1158/1541-7786.22521039

2023-01-01

Abstract:Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling
Supplementary Figures S1-S6 from Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer Via Its Promotion of Intratumoral Androgen Biosynthesis

Li Xiao,Yuliang Wang,Ke Xu,Hao Hu,Zhenyu Xu,Dinglan Wu,Zhu Wang,Wenxing You,Chi‐Fai Ng,Shuhui Yu,F.H.Y. Chan

DOI: https://doi.org/10.1158/0008-5472.22419014.v1

2023-01-01

Abstract:Supplementary Figures S1-S6
Supplementary Figure 1 from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation Via the Activation of Stat3/Bcl-2 Pathway

Dong Zhang,Dalin He,Yan Xue,Ruoxiang Wang,Kaijie Wu,Hongjun Xie,Jin Zeng,Xinyang Wang,Haiyen E. Zhau,Leland W.K. Chung,Luke S. Chang,Lei Li

DOI: https://doi.org/10.1158/0008-5472.22387082

2023-01-01

Abstract:Supplementary Figure 1 from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway
Supplementary Methods, Figure Legend from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation Via the Activation of Stat3/Bcl-2 Pathway

Dong Zhang,Dalin He,Yan Xue,Ruoxiang Wang,Kaijie Wu,Hongjun Xie,Jin Zeng,Xinyang Wang,Haiyen E. Zhau,Leland W.K. Chung,Luke S. Chang,Lei Li

DOI: https://doi.org/10.1158/0008-5472.22387079

2023-01-01

Abstract:Supplementary Methods, Figure Legend from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway
Antiproliferation of Berberine is Mediated by Epigenetic Modification of Constitutive Androstane Receptor (car) Metabolic Pathway in Hepatoma Cells

Lei Zhang,Xiao-Jie Miao,Xin Wang,Hai-Hui Pan,Pu Li,Hong Ren,Yong-Rui Jia,Chuang Lu,Hong-Bing Wang,Lan Yuan,Guo-Liang Zhang

DOI: https://doi.org/10.1038/srep28116

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Constitutive androstane receptor (CAR) regulates hepatic xenobiotic and energy metabolism, as well as promotes cell growth and hepatocarcinogenesis. Berberine is an ancient multipotent alkaloid drug which derived from Coptis chinensis plants. Here we report that berberine is able to be cellular uptake and accessible to chromatin in human hepatoma HepG2 cells. Berberine induces more apoptosis, cell cycle arrest, but less ROS production in CAR overexpressed mCAR-HepG2 cells. Moreover, berberine inhibits expressions of CAR and its target genes CYP2B6 and CYP3A4. Furthermore, berberine enhances DNA methylation level in whole genome but reduces that in promoter regions CpG sites of CYP2B6 and CYP3A4 genes under the presence of CAR condition. These results indicated that the antiproliferation of berberine might be mediated by the unique epigenetic modifying mechanism of CAR metabolic pathway, suggesting that berberine is a promising candidate in anticancer adjuvant chemotherapy, due to its distinct pharmacological properties in clinic.
Supplementary Methods and Figure Legends from Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer Via Its Promotion of Intratumoral Androgen Biosynthesis

Lijia Xiao,Yuliang Wang,Kexin Xu,Hao Hu,Zhenyu Xu,Dinglan Wu,Zhu Wang,Wenxing You,Chi-Fai Ng,Shan Yu,Franky Leung Chan

DOI: https://doi.org/10.1158/0008-5472.22419011

2023-01-01

Abstract:Supplementary Methods and Figure Legends
Supplementary Figure Legends from birc6 Targeting As Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer

Iris Sze Ue Luk,Raunak Shrestha,Xue Han,Yuwei Wang,Fang Zhang,Dongxin Lin,Anne Haegert,Rebecca Wu,Xinyong Dong,Colin C. Collins,Amina Zoubeidi,Martin E. Gleave,Peter W. Gout,Yuzhuo Wang

DOI: https://doi.org/10.1158/1078-0432.22464480

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figure from Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition

Guoyu Yu,Paul G. Corn,Pengfei Shen,Jian H. Song,Yu-Chen Lee,Song-Chang Lin,Jing Pan,Sandeep K. Agarwal,Theocharis Panaretakis,Maurizio Pacifici,Christopher J. Logothetis,Li-Yuan Yu-Lee,Sue-Hwa Lin

DOI: https://doi.org/10.1158/0008-5472.can-22-0170

2023-01-01

Abstract:Supplementary Figure from Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition
Supplementary Figure S1 from Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer

Cameron M. Armstrong,Chengfei Liu,Liangren Liu,Joy C. Yang,Wei Lou,Ruining Zhao,Shu Ning,Alan P. Lombard,Jinge Zhao,Leandro S. D'Abronzo,Christopher P. Evans,Pui-Kai Li,Allen C. Gao

DOI: https://doi.org/10.1158/1078-0432.22476678.v1

2023-01-01

Abstract:STS activity
Supplementary Figure 7 from ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling Pathway

Dalin He,Lei Li,Guodong Zhu,Liang Liang,Zhenfeng Guan,Luke Chang,Yuan Chen,Shuyuan Yeh,Chawnshang Chang

DOI: https://doi.org/10.1158/0008-5472.22402343

2023-01-01

Abstract:PDF file - 3303K, Figure. S7. blocking AR signaling could inhibit AR positive cell migration, invasion and proliferation in a concentration-dependent in vivo and in vitro.

Supplementary Figure 5 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Supplementary Figure 4 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Supplementary Figure 6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Supplementary Figure 2 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Supplementary Figure Legends 1-6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Data from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Supplementary Figures S1 - S7 from Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway

Berberine Inhibits Androgen Synthesis by Interaction with Aldo-Keto Reductase 1C3 in 22rv1 Prostate Cancer Cells

Supplementary Figure 4 from Spongian Diterpenoids Inhibit Androgen Receptor Activity

Supplementary Figure 3 from ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment

Supplementary Figure from Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation

Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth Through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Supplementary Figures S1-S6 from Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer Via Its Promotion of Intratumoral Androgen Biosynthesis

Supplementary Figure 1 from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation Via the Activation of Stat3/Bcl-2 Pathway

Supplementary Methods, Figure Legend from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation Via the Activation of Stat3/Bcl-2 Pathway

Antiproliferation of Berberine is Mediated by Epigenetic Modification of Constitutive Androstane Receptor (car) Metabolic Pathway in Hepatoma Cells

Supplementary Methods and Figure Legends from Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer Via Its Promotion of Intratumoral Androgen Biosynthesis

Supplementary Figure Legends from &lt;i&gt;birc6&lt;/i&gt; Targeting As Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer

Supplementary Figure from Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition

Supplementary Figure S1 from Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer

Supplementary Figure 7 from ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling Pathway

Supplementary Figure Legends from <i>birc6</i> Targeting As Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer